Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

Yamamoto, Suguru

Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. [electronic resource] - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Aug 2011 - 2491-7 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1460-2385

10.1093/ndt/gfq759 doi


Administration, Oral
Animals
Apolipoproteins E--physiology
Atherosclerosis--etiology
Carbon--administration & dosage
Charcoal--metabolism
Chemokine CCL2--genetics
Female
Immunoenzyme Techniques
Interleukin-1beta--genetics
Kidney Diseases--complications
Kidney Function Tests
Mice
Mice, Inbred C57BL
Mice, Knockout
Oxides--administration & dosage
RNA, Messenger--genetics
Reverse Transcriptase Polymerase Chain Reaction
Tumor Necrosis Factor-alpha--genetics